Atricure Stock Odds of Future Stock Price Finishing Under 27.91

ATRC Stock  USD 23.17  0.46  2.03%   
AtriCure's implied volatility is one of the determining factors in the pricing options written on AtriCure. Implied volatility approximates the future value of AtriCure based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in AtriCure over a specific time period. For example, 2024-05-17 CALL at $22.5 is a CALL option contract on AtriCure's common stock with a strick price of 22.5 expiring on 2024-05-17. The contract was last traded on 2024-04-17 at 13:16:12 for $2.65 and, as of today, has 24 days remaining before the expiration. The option is currently trading at a bid price of $0.15, and an ask price of $2.05. The implied volatility as of the 24th of April is 41.12. View All AtriCure options

Closest to current price AtriCure long CALL Option Payoff at Expiration

AtriCure's future price is the expected price of AtriCure instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of AtriCure performance during a given time horizon utilizing its historical volatility. Check out AtriCure Backtesting, AtriCure Valuation, AtriCure Correlation, AtriCure Hype Analysis, AtriCure Volatility, AtriCure History as well as AtriCure Performance.
For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.
  
At present, AtriCure's Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Operating Cash Flows Ratio is expected to grow to 392.27, whereas Price To Sales Ratio is forecasted to decline to 3.93. Please specify AtriCure's target price for which you would like AtriCure odds to be computed.

AtriCure Target Price Odds to finish below 27.91

The tendency of AtriCure Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under $ 27.91  after 90 days
 23.17 90 days 27.91 
about 19.92
Based on a normal probability distribution, the odds of AtriCure to stay under $ 27.91  after 90 days from now is about 19.92 (This AtriCure probability density function shows the probability of AtriCure Stock to fall within a particular range of prices over 90 days) . Probability of AtriCure price to stay between its current price of $ 23.17  and $ 27.91  at the end of the 90-day period is about 17.71 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.16 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, AtriCure will likely underperform. Additionally AtriCure has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
   AtriCure Price Density   
       Price  

Predictive Modules for AtriCure

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as AtriCure. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of AtriCure's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
19.8822.6425.40
Details
Intrinsic
Valuation
LowRealHigh
20.8532.7835.54
Details
9 Analysts
Consensus
LowTargetHigh
59.4565.3372.52
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.3-0.23-0.2
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as AtriCure. Your research has to be compared to or analyzed against AtriCure's peers to derive any actionable benefits. When done correctly, AtriCure's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in AtriCure.

AtriCure Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. AtriCure is not an exception. The market had few large corrections towards the AtriCure's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold AtriCure, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of AtriCure within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.71
β
Beta against NYSE Composite2.16
σ
Overall volatility
4.10
Ir
Information ratio -0.23

AtriCure Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of AtriCure for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for AtriCure can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
AtriCure generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 399.25 M. Net Loss for the year was (30.44 M) with profit before overhead, payroll, taxes, and interest of 245.94 M.
Over 97.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: AtriCures cryoSPHERE Probe to Aid in Pain Management

AtriCure Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of AtriCure Stock often depends not only on the future outlook of the current and potential AtriCure's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AtriCure's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding46.3 M
Cash And Short Term Investments137.3 M

AtriCure Technical Analysis

AtriCure's future price can be derived by breaking down and analyzing its technical indicators over time. AtriCure Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of AtriCure. In general, you should focus on analyzing AtriCure Stock price patterns and their correlations with different microeconomic environments and drivers.

AtriCure Predictive Forecast Models

AtriCure's time-series forecasting models is one of many AtriCure's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary AtriCure's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about AtriCure

Checking the ongoing alerts about AtriCure for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for AtriCure help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
AtriCure generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 399.25 M. Net Loss for the year was (30.44 M) with profit before overhead, payroll, taxes, and interest of 245.94 M.
Over 97.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: AtriCures cryoSPHERE Probe to Aid in Pain Management
When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:
Check out AtriCure Backtesting, AtriCure Valuation, AtriCure Correlation, AtriCure Hype Analysis, AtriCure Volatility, AtriCure History as well as AtriCure Performance.
For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for AtriCure Stock analysis

When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Is AtriCure's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.66)
Revenue Per Share
8.621
Quarterly Revenue Growth
0.21
Return On Assets
(0.03)
Return On Equity
(0.07)
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.